TY  - JOUR
AU  - Vigil, Karen
AU  - Bhatnagar, Sonal
AU  - Bell, Cynthia
AU  - Swinford, Rita
AU  - DeGolovine, Aleksandra
AU  - Hebert, Sean
PY  - 2018
DA  - 2018/08/14
TI  - Acceptance of HPV Vaccination in Kidney Transplant Recipients
JO  - OBM Transplantation
SP  - 017
VL  - 02
IS  - 03
AB  - Background: Human Papilloma virus (HPV) infections are an increasingly concerning etiology for post-transplantation viral-related malignancies. The nonavalent HPV vaccine (Gardasil 9) affords transplant recipients the best opportunity for malignancy prevention, but remains underutilized. Not previously reported for solid organ transplant recipients, we studied influential factors for HPV vaccine non-initiation.

Methods: This survey, conducted from May to December 2017, examined influential factors for HPV vaccine non-initiation. HPV-related disease period prevalence was also analyzed in this regional survey.

Results: Of the 164 patients approached for the study, 157 participated and 154 completed the survey resulting in a 95% response rate. Twenty-nine percent of patients within the United States Food and Drug Administration (FDA) approved age range had started or completed the HPV vaccine series at survey administration. The most significant reason for HPV vaccine non-initiation among age eligible transplant patients was a reduced physician intention to recommend.

Conclusion: HPV vaccination remains underutilized in solid organ transplant patients. Emphasis on physician intention to recommend HPV vaccination will reduce vaccine non-initiation rates.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.1803017
DO  - 10.21926/obm.transplant.1803017
ID  - Vigil2018
ER  -